Use our chat feature to speak with one of our expert consultants who can help you identify if medical cannabis can help you.
Stay updated with the latest trends, news, and developments in the UK medical cannabis industry, from regulations to market growth and innovations.
With extended families coming together and immediate families typically spending long periods of time together over the Christmas period, catching up on what everyone has been up to over the last year is a common course conversation takes.
With UK medical cannabis going nothing short of viral in the past 12 months or so (and patient numbers climbing at an exponential rate), the need for clear, concise information regarding medical cannabis accessories has never been more obvious.
Growing awareness and acceptance of cannabis-based products has been on the rise in recent years. In addition to a flourishing CBD consumer market, medical cannabis has become increasingly accessible to patients with a variety of health concerns.
This year, we’ve taken a leaf from Spotify’s book and put together a collection of our favourite moments during 2024. As the year draws to a close, here we reflect on our milestones, growth, and most importantly, the transformative difference we’re making for patients.
With the holiday season less than two weeks away, we want to make sure each and every Releaf patient is well-prepared for the slight changes to our normal operating schedule - and the minor adjustments to medication delivery during this year's festive period.
The holiday season is fast approaching, and with it, the yearly yearning to pack your bags, hit the road and hopefully escape the winter blues.
The days are drawing in and Christmas is right around the corner. Many of us will be working our way down Christmas lists, trying to find the perfect presents for our loved ones.
Around the world, 1.3 billion, or 1 in 6, people live with a disability - yet many face barriers when accessing adequate healthcare services. At Releaf, it's important to us to participate in events like International Day of Persons with Disabilities, and so that’s exactly what we’re doing.
Last year, our representative research found 68% of UK adults would consider medical cannabis treatment if their doctor recommended it, but around 1 in 4 said they would be apprehensive about, and perhaps discouraged by, the costs involved.
There has been a huge resurgence in interest in plant-based health solutions in the past few decades. Not so long ago, most patients would just take whatever pharmaceutical options their GPs prescribed - but as we mature as a society and our collective understanding of alternative medicine grows, the understanding that plants can offer natural relief from a huge range of symptoms grows.
Disability History Month, taking place from 14 November— 20 December highlights the history of the equality and human rights struggles of disabled individuals in the UK.
As new findings from an early health economic analysis suggest that prescribing medical cannabis on the NHS to treat chronic pain could save the state healthcare provider almost £4 billion every year, we take a closer look at the research.
Friday the 1st of November 2024 marks six years of medical cannabis in the UK. For the last six years, (since November 1, 2018) specialist doctors like those working at Releaf have been able to prescribe medical cannabis flower, and cannabis oil, to eligible patients when traditional treatments have proved ineffective.
While awareness of medical cannabis has grown in recent years, there remains a huge knowledge gap when it comes to healthcare professionals and their understanding of this treatment.
Medical cannabis was legalised almost 6 years ago as an alternative treatment option for a large volume of health conditions when conventional approaches have proved ineffective.
Medical cannabis has been prescribed for a wide range of conditions in the UK since the legislation of cannabis-based treatments on the 1st of November 2018. Since then, tens of thousands of patients have received a prescription for cannabis-based medicines; however, there are several conditions, including schizoaffective disorder, for which medical cannabis is not considered a suitable option. But why is this?
In this article, we explore the distinction between illegal, unregulated THC vape pens and legally prescribed medical cannabis flower. Understanding the difference is crucial— especially for patients— when it comes to making informed choices about your health.
The medicinal potential of cannabis and its derivatives has been a focus of medical research for hundreds of years. Yet, there remains a significant number of unknowns around this complex and versatile plant. With that in mind, we’re taking a closer look at some of the most significant medical cannabis research published so far in 2024.
Now that medical cannabis has been legally available in the UK for almost six years, powerful patient testimonials are hitting the press highlighting how medical cannabis has helped people manage PTSD, depression, and anxiety symptoms.
Curious as to who can prescribe medical cannabis in the UK? Well, meet Releaf’s team of specialists, from GPs to specialists n Neurology, Psychiatry, Oncology, Rheumatology and Palliative Care, our clinical team collaborate to create the best bespoke treatment plan possible, for each individual patient.
With a large proportion of Releaf patients choosing the Omura Vaporiser to "heat, not burn" their prescribed medical cannabis flower options, we thought it was about time to quickly discuss how to use the Flowerstick Home Fill System.
Patients in France could soon have widespread access to medical cannabis on prescription as a three-year pilot study prepares to come to a close.
Much like all other treatment options in the UK, medical cannabis does come with costs. But, here at Releaf we do our best to balance bespoke, specialised care with affordable and accessible treatment plans, and our ever-growing patient numbers and reams of positive reviews on Trust Pilot, show we’re keeping the scales in check.
